ICU Medical Inc., a supplier of infusion therapy-related medical equipment, reported fourth quarter revenue and profit that ...

Raymond James upgraded ICU Medical (ICUI) to Strong Buy from Outperform with a price target of $97, down from $205. The firm believes the ...

Raymond James added ICU Medical (ICUI) to the firm’s Analyst Current Favorites list. The list contains the current favorite stock ideas from ...

The two-year program will offer advanced training for doctors who have already completed a three-year residency in internal ...

SAN CLEMENTE, Calif., March 07, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company ...

Q4 2024 Earnings Call Transcript February 27, 2025 ICU Medical, Inc. beats earnings expectations. Reported EPS is $2.11, expectations were $1.48. Operator: Good day. And welcome to the ICU Medical, ...

ICU Medical has a beta of 0.63, indicating that its share price is 37% less volatile than the S&P 500. Comparatively, MiMedx Group has a beta of 1.97, indicating that its share price is 97% more ...

Medical device company ICU Medical (NASDAQ:ICUI) will be reporting results tomorrow after market close. Here’s what you need to know. ICU Medical beat analysts’ revenue expectations by 1% last ...

Shareholders might have noticed that ICU Medical, Inc. (NASDAQ:ICUI) filed its annual result this time last week. The early response was not positive, with shares down 7.0% to US$146 in the past week.

Medical device company ICU Medical (NASDAQ:ICUI) reported Q4 CY2024 results , with sales up 7.1% year on year to $629.8 million. Its non-GAAP profit of $2.11 per share was 42.4% above analysts’ ...

SAN CLEMENTE, Calif., March 07, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company ...